American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

 

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments […]

 

Learn More

 

 

Dr. Heuser’s Prostate Cancer Story

 

  Watch general surgeon, Dr. Louis Heuser, talk about why he chose CyberKnife for the treatment of his prostate cancer. Dr. Heuser was very happy with the quick treatments and the fact that he was able to stay close to home and continue to work and see his patients. It’s Your Prostate, Your Cancer, Your […]

 

Learn More

 

 

Dr. Cox Discusses Prostate Cancer on Studio 512

 

 

Learn More

 

 

Scientists Find New Gene Tool for Predicting Course of Prostate Cancer

 

A recent research paper in Oncotarget, a weekly peer-reviewed open access medical journal covering research on all aspects of oncology, reported that researchers from UR Medicine’s Wilmot Cancer Institute and Roswell Park Cancer Institute have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of […]

 

Learn More

 

 

Dr. Rivera Discusses Prostate Cancer on Studio 512

 

 

Learn More

 

 

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

 

According to research presented at the recent 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), high dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates.    Although prostate tumors generally respond well to radiation […]

 

Learn More

 

 

Screening Strategy May Predict Lethal Prostate Cancer Later in Life

 

A recent study found that mid-life prostate-specific antigen (PSA) levels predict who will be more likely to develop lethal prostate cancer.  Investigators from Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health found that measuring PSA levels in younger men (between the ages of 40 and 59) could accurately predict future […]

 

Learn More

 

 

Infographic: 8 Common Symptoms of Prostate Cancer

 

 

Learn More

 

 

Managing Cancer as a Chronic Illness

 

June is National Cancer Survivor Month.  It is a month dedicated to celebrating and recognizing those who have survived cancer, an inspiration for those recently diagnosed, a gathering of support for families, and an outreach to the community.   According to the Centers for Disease Control and Prevention (CDC), the leading national public health institute […]

 

Learn More

 

 

Dr. Matthew McCurdy’s prostate cancer interview with KXAN-TV

 

 

Learn More